343 related articles for article (PubMed ID: 27179404)
1. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
[TBL] [Abstract][Full Text] [Related]
3. Transarterial embolization with sorafenib in animal livers: a pharmacokinetics study.
Chatziioannou AN; Siskos AP; Loxas D; Kavatzas N; Agrogiannis G; Fokas D; Malagari K; Kostomitsopoulos NG; Tsigkou O; Tamvakopoulos C
J Vasc Interv Radiol; 2013 Nov; 24(11):1657-63.e1. PubMed ID: 24060438
[TBL] [Abstract][Full Text] [Related]
4. Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model.
Gaba RC; Yap FY; Martinez EM; Li Y; Guzman G; Parvinian A; van Breemen RB; Kumar N
J Vasc Interv Radiol; 2013 May; 24(5):744-50. PubMed ID: 23510657
[TBL] [Abstract][Full Text] [Related]
5. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.
Lee IJ; Lee M; Kim SJ; Kim YK; Won JY; Chung JW
J Vasc Interv Radiol; 2018 Aug; 29(8):1078-1084. PubMed ID: 29910164
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
Wang Y; Zheng C; Liang B; Zhao H; Qian J; Liang H; Feng G
J Vasc Interv Radiol; 2011 Nov; 22(11):1606-12. PubMed ID: 21959058
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.
Elkhadragy L; Khabbaz RC; Muchiri RN; Totura WM; Samuelson JP; Whiteley HE; van Breemen RB; Lokken RP; Gaba RC
J Vasc Interv Radiol; 2022 Oct; 33(10):1213-1221.e5. PubMed ID: 35850455
[TBL] [Abstract][Full Text] [Related]
8. Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model.
Seidensticker M; Streit S; Nass N; Wybranski C; Jürgens J; Brauner J; Schulz N; Kalinski T; Seidensticker R; Garlipp B; Steffen I; Ricke J; Dudeck O
Diagn Interv Radiol; 2016; 22(4):378-84. PubMed ID: 27328720
[TBL] [Abstract][Full Text] [Related]
9. [Transhepatic arterial embolization with superparamagnetic iron oxide and lipiodol for the treatment of VX2 tumor in rabbits].
Liang Q; Deng L; Feng Z; Liu X; Ding J; Hu P; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 42(11):1248-1256. PubMed ID: 29187650
[TBL] [Abstract][Full Text] [Related]
10. Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors.
Rhee TK; Young JY; Larson AC; Haines GK; Sato KT; Salem R; Mulcahy MF; Kulik LM; Paunesku T; Woloschak GE; Omary RA
J Vasc Interv Radiol; 2007 May; 18(5):639-45. PubMed ID: 17494846
[TBL] [Abstract][Full Text] [Related]
11. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor Effects of Sorafenib Administered at Different Time Points in Combination with Transarterial Embolization in a Rabbit VX2 Liver Tumor Model.
Tomozawa Y; Nitta N; Ohta S; Watanabe S; Sonoda A; Nitta-Seko A; Tsuchiya K; Murata K
Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1763-1768. PubMed ID: 28593395
[TBL] [Abstract][Full Text] [Related]
13. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
14. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study.
Sato Y; Nishiofuku H; Yasumoto T; Nakatsuka A; Matsuo K; Kodama Y; Okubo H; Abo D; Takaki H; Inaba Y; Yamakado K
J Vasc Interv Radiol; 2018 Aug; 29(8):1061-1067. PubMed ID: 29934260
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Geschwind JF; Chapiro J
Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
[No Abstract] [Full Text] [Related]
18. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model.
Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM
Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023
[TBL] [Abstract][Full Text] [Related]
19. Use of a Glass Membrane Pumping Emulsification Device Improves Systemic and Tumor Pharmacokinetics in Rabbit VX2 Liver Tumor in Transarterial Chemoembolization.
Masada T; Tanaka T; Nishiofuku H; Fukuoka Y; Taiji R; Sato T; Tatsumoto S; Minamiguchi K; Marugami N; Kichikawa K
J Vasc Interv Radiol; 2020 Feb; 31(2):347-351. PubMed ID: 31542274
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
